Skip to content

Clinical trials

Cardiovascular Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Australia Clear all

132 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20042
20051
20062
20072
20085
20095
20106
20117
201211
20136
20147
20154
20165
20173
201810
20195
20203
20214
20226
20237
20247
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Recruiting18
Active, not recruiting13
Terminated10
Unknown status5
Not yet recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen6
Eli Lilly and Company6
Abbott Medical Devices5
AstraZeneca5
Boston Scientific Corporation5
Medtronic Vascular5
Monash University5
Bayside Health4
GlaxoSmithKline4
Kirby Institute4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases132
Vascular Diseases24
Heart Diseases22
Stroke18
Hypertension15
Myocardial Infarction15
Atherosclerosis13
Diabetes Mellitus, Type 213
Heart Failure10
Cerebrovascular Disorders9

Trials

Showing 1 to 25 of 132. Each trial links to its page on Pharma Observatory.

32 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.